Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Gavrilova, Si"'
Autor:
E. V. Ponomareva, Selezneva Nd, Gavrilova Si, N A Didkovsky, Ya. B. Fedorova, I. V. Kolykhalov, N. A. Khailov, S A Krynskiy, I K Malashenkova, D P Ogurtsov
Publikováno v:
Medicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 805-812 (2021)
Alzheimer’s disease (AD) is currently the most common cause of dementia. A significant role in the pathogenesis of AD belongs to the activation of the mechanisms of neuroinflammation. There is a hypothesis that chronic infections may play a role in
Autor:
I K Malashenkova, S A Krynskiy, E. Yu. Moskaleva, Gavrilova Si, Yu. P. Semochkina, D P Ogurtsov, N A Hailov, E. V. Ponomareva
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 15:139-146
The individual differences in the efficiency of DNA DSB repair were estimated by the level of residual γH2AX foci after γ-irradiation at a dose of 2 Gy, in lymphocytes of patients with amnestic mild cognitive impairment (AMCI) and Alzheimer's disea
Autor:
Boris B. Velichkovsky, Alena A. Khlebnikova, Dmitry V. Tatarinov, Natalia D. Selezneva, Gavrilova Si, Roshchina If
Publikováno v:
Psychology in Russia: State of the Art. 13:109-120
Publikováno v:
Drug Design, Development and Therapy, Vol 2012, Iss default, Pp 53-60 (2012)
Paul H Caldron1, Svetlana I Gavrilova2, Siegfried Kropf31Midwestern University, Arizona College of Osteopathic Medicine, Glendale, AZ, USA; 2Mental Health Research Center of the Russian Academy of Medical Sciences, Moscow, Russian Federation; 3Instit
Externí odkaz:
https://doaj.org/article/c392e5974c9441759cf7f272c137cc94
Autor:
E. V. Ponomareva, D. O. Koroev, A. V. Kamynina, Olga M. Volpina, I. V. Kolykhalov, Ya. B. Fedorova, Selezneva Nd, Gavrilova Si
Publikováno v:
Neuroscience and Behavioral Physiology. 49:523-534
Objectives. Therapeutic monitoring and evaluation of the efficacy of neurotrophic therapy in patients with amnestic-type mild cognitive decline syndrome (aMCI) were performed in a model using courses of cerebrolysin. Materials and methods. A total of
Autor:
E. V. Ponomareva, Gavrilova Si, N A Didkovsky, Boris M. Velichkovsky, D P Ogurtsov, I K Malashenkova, S A Krynskiy, E I Chekulaeva, O Y Shipulina, N. A. Khailov
Publikováno v:
Voprosy virusologii. 66(2)
Introduction. Alzheimer’s disease (AD) is a multifactorial disease that leads to a progressive memory loss, visualspatial impairments, emotional and personality changes. As its earliest pre-dementia clinical stage, amnestic mild cognitive impairmen
Autor:
Nikolay Didkovsky, N A Hailov, S A Krynskiy, D P Ogurtsov, I K Malashenkova, Gavrilova Si, E I Chekulaeva, Elena Ponomareva
Publikováno v:
Neuroscience for Medicine and Psychology.
Autor:
Selezneva Nd, Gavrilova Si, Ya. B. Fedorova, E. V. Ponomareva, U A Gutner, A. V. Alesenko, I. V. Kolykhalov, M. A. Shupik, A. O. Lebedeva
Publikováno v:
Neuroscience and Behavioral Physiology. 49:147-152
Objectives. To determine the efficacy and safety of treatment with Cereton (alfoscerate) in patients with mild cognitive impairment syndrome (MCI) and its effects during and after treatment on phosphatidyl-choline, sphingomyelin, and ceramide (a sphi
Autor:
G. V. Kazanova, Ya. B. Fedorova, N. A. Khailov, I K Malashenkova, N. A. Didkovskii, E. V. Ponomareva, Selezneva Nd, Gavrilova Si, D P Ogurtsov, B. B. Velichkovskii, I. V. Kolykhalov, S. A. Krynskii
Publikováno v:
Neuroscience and Behavioral Physiology. 47:694-698
Objective. To assess the levels of cytokines (IFN-α, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-15, TNF-α) and IL-1 receptor antagonist (IL-1RA), as well as the levels of vascular endothelial growth factor (VEGF) and its antagonist – soluble recept
Publikováno v:
Neuroscience and Behavioral Physiology. 47:382-385
Objective. To perform a comparative analysis of changes in the functional status of the brain by quantitative electroencephalography (EEG) during combined antidepressant treatment (venlafaxine and Cerebrolysin) and monotherapy (venlafaxine) of elderl